Swiss drugmaker Roche said on Friday it will start selling a new digital diagnostics product that may simplify and accelerate screening of patients with breathing problems during the COVID-19 pandemic.

Roche’s v-TAC, a new digital diagnostic solution that could help clinicians get faster results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a puncture in a vein, is available in markets that accept the CE mark, the company said.

Reuters